Drug Information

Drug General Information
Drug ID
D07FFB
Former ID
DNC013337
Drug Name
Carinatumins B (2)
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528591]
Structure
Download
2D MOL

3D MOL
Formula
C16H20N2O2
Canonical SMILES
CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2C(CCN4)O
InChI
1S/C16H20N2O2/c1-9-6-10-7-12-11(2-3-14(20)18-12)16(8-9)15(10)13(19)4-5-17-16/h2-3,6,10,13,15,17,19H,4-5,7-8H2,1H3,(H,18,20)/t10-,13+,15-,16-/m0/s1
InChIKey
RGJUWLMFRYLAOJ-UXVLEFJLSA-N
PubChem Compound ID
44428320
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [528591]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 528591Bioorg Med Chem. 2007 Feb 15;15(4):1703-7. Epub 2006 Dec 15.Carinatumins A-C, new alkaloids from Lycopodium carinatum inhibiting acetylcholinesterase.
Ref 528591Bioorg Med Chem. 2007 Feb 15;15(4):1703-7. Epub 2006 Dec 15.Carinatumins A-C, new alkaloids from Lycopodium carinatum inhibiting acetylcholinesterase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.